Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
r80cLrEvnpYHxRPT
Listen
